Zobrazeno 1 - 10
of 74
pro vyhledávání: '"L Tixi"'
Autor:
Tino Ceschia, Pierina Navarria, Filippo de Marinis, Francesco Grossi, Lucio Buffoni, L. Loreggian, Paal Fr Bruswig, Adolfo Favaretto, Massimo Di Maio, L. Tixi, Luca Boni, Brunello Morrica, Rudolf M. Huber, Giorgio V. Scagliotti, Santi Barbera, C. Caroti, Vito D'Alessandro, Andrea Ardizzoni, Ornella Belvedere, Umberto Ricardi, Andrea Grimaldi, Marcello Tiseo, Diego Cortinovis, Salvatore Parisi, Chandra P. Belani, Tindaro Scolaro
Background Chemo-radiotherapy is standard of care in the treatment of unresectable stage III NSCLC. We aimed at assessing whether the addition of concurrent taxane-chemotherapy to thoracic irradiation following chemotherapy was able to improve treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c04b291665c3f7da1eb9a7bd8379be4f
http://hdl.handle.net/11585/591305
http://hdl.handle.net/11585/591305
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alberto Ballestrero, L. Tixi, Andrea Massobrio, Roberto Murialdo, Stefano Scabini, Federica Grillo, R. Gonella, Emanuele Romairone, Edoardo Rimini, C. Marrone, G. Cittadini, Luca Mastracci, A. Bacigalup, Gabriele Zoppoli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbcbacf9cf6f853e42089be20b3c18f1
http://hdl.handle.net/11567/809571
http://hdl.handle.net/11567/809571
Autor:
E. Stratta, Emanuele Romairone, Stefano Scabini, L. Tixi, E. Harusha, A. Ghiglione, Roberto Murialdo, Alberto Ballestrero, M. Sparavigna, Gabriele Zoppoli
Publikováno v:
Annals of Oncology. 28:vi13
Autor:
Almalina Bacigalupo, Roberto Murialdo, Stefano Scabini, Liliana Belgioia, A. Ghiglione, Alberto Ballestrero, Gabriele Zoppoli, E. Harusha, Renzo Corvò, Emanuele Romairone, L. Tixi
Publikováno v:
Annals of Oncology. 28:vi6
Publikováno v:
Critical Reviews in Oncology/Hematology. 37:61-67
Brain is the most common site of metastatic spread in small-cell lung cancer (SCLC). Approximately 10% of SCLC patients have brain metastases (BM) already at diagnosis and an additional 40% will develop central nervous system (CNS) involvement during
Autor:
Franca Foppiano, Vito Vitale, Luca Boni, Carlo Mereu, F. Grossi, R. Rosso, Andrea Ardizzoni, M. Cosso, G Battista Ratto, S Giudici, T. Scolaro, L Tixi
Publikováno v:
British Journal of Cancer
Both induction chemotherapy and concurrent low-dose cisplatin have been shown to improve results of thoracic irradiation in the treatment of locally advanced non-small-cell lung cancer (NSCLC). This phase II study was designed to investigate activity
Publikováno v:
Drugs. 55:47-58
Malignant pleural effusions (MPEs) represent a common complication of advanced malignancies. However, adequate palliation of this highly symptomatic accompaniment to cancer can be achieved in most patients by adopting the appropriate therapy. Several
Autor:
R. Labianca, R. Rosso, L. Tixi, Alberto Sobrero, M. Vinci, Carlo Aschele, Carlo Milandri, E. Ciferri, E. Verdi, C. Caroti, Giovanni Luca Frassineti, A. Guglielmi, Dino Amadori
Publikováno v:
British Journal of Cancer
Scopus-Elsevier
Scopus-Elsevier
We have recently reported high clinical activity against advanced colorectal cancer of a regimen-alternating bolus FUra, modulated by methotrexate (MTX), and continuous infusion FUra, modulated by 6-s-leucovorin (6-s-LV). Considering the low toxicity
Autor:
A. Guglielmi, E. Bolli, B. Ligas, V. Pugliese, L. Tixi, S. Saccomanno, M. Connio, G. Mondini, Alberto Sobrero, A. Mori, Carlo Aschele, R. Rosso
Publikováno v:
Cancer Chemotherapy and Pharmacology. 35:339-342
A total of 20 patients with advanced pancreatic adenocarcinoma were enrolled in a phase II trial testing the activity of 5-fluorouracil given at 370 mg/m2 as a rapid i. v. bolus for 5 consecutive days, preceded by a rapid i. v. bolus of 200 mg/m2 5-m